393 related articles for article (PubMed ID: 11145675)
1. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question.
Suchin EJ; Langmuir PB; Palmer E; Sayegh MH; Wells AD; Turka LA
J Immunol; 2001 Jan; 166(2):973-81. PubMed ID: 11145675
[TBL] [Abstract][Full Text] [Related]
2. Human vascular endothelial cells stimulate a lower frequency of alloreactive CD8+ pre-CTL and induce less clonal expansion than matching B lymphoblastoid cells: development of a novel limiting dilution analysis method based on CFSE labeling of lymphocytes.
Dengler TJ; Johnson DR; Pober JS
J Immunol; 2001 Mar; 166(6):3846-54. PubMed ID: 11238628
[TBL] [Abstract][Full Text] [Related]
3. Tracking alloreactive cell division in vivo.
Song HK; Noorchashm H; Lieu YK; Rostami S; Greeley SA; Barker CF; Naji A
Transplantation; 1999 Jul; 68(2):297-9. PubMed ID: 10440405
[TBL] [Abstract][Full Text] [Related]
4. Induction of acute graft-versus-host disease by T cells that do not respond to in vitro alloantigen stimulation.
New JY; Chan SH; Yap EH; Hu H
Br J Haematol; 2004 Sep; 126(6):828-36. PubMed ID: 15352987
[TBL] [Abstract][Full Text] [Related]
5. Increased severity of murine lupus in female mice is due to enhanced expansion of pathogenic T cells.
Lang TJ; Nguyen P; Papadimitriou JC; Via CS
J Immunol; 2003 Dec; 171(11):5795-801. PubMed ID: 14634088
[TBL] [Abstract][Full Text] [Related]
6. "Pruning" of alloreactive CD4+ T cells using 5- (and 6-)carboxyfluorescein diacetate succinimidyl ester prolongs skin allograft survival.
Watson D; Zhang GY; Sartor M; Alexander SI
J Immunol; 2004 Dec; 173(11):6574-82. PubMed ID: 15557147
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of memory T cell proliferation under conditions of heterologous immunity and bystander stimulation.
Kim SK; Brehm MA; Welsh RM; Selin LK
J Immunol; 2002 Jul; 169(1):90-8. PubMed ID: 12077233
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells prime in vivo alloreactive CD4 T lymphocytes toward type 2 cytokine- and TGF-beta-producing cells in the absence of CD8 T cell activation.
Foucras G; Coudert JD; Coureau C; Guéry JC
J Immunol; 2000 Nov; 165(9):4994-5003. PubMed ID: 11046027
[TBL] [Abstract][Full Text] [Related]
9. Activated allogeneic NK cells as suppressors of alloreactive responses.
Hu B; He Y; Wu Y; Bao G; Liu H; Welniak LA; Murphy WJ
Biol Blood Marrow Transplant; 2010 Jun; 16(6):772-81. PubMed ID: 20197103
[TBL] [Abstract][Full Text] [Related]
10. Division rate and phenotypic differences discriminate alloreactive and nonalloreactive T cells transferred in lethally irradiated mice.
Maury S; Salomon B; Klatzmann D; Cohen JL
Blood; 2001 Nov; 98(10):3156-8. PubMed ID: 11698305
[TBL] [Abstract][Full Text] [Related]
11. Distribution of cycling T lymphocytes in blood and lymphoid organs during immune responses.
Vasseur F; Le Campion A; Pavlovitch JH; Pénit C
J Immunol; 1999 May; 162(9):5164-72. PubMed ID: 10227988
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine-1-phosphate receptor agonism impairs the efficiency of the local immune response by altering trafficking of naive and antigen-activated CD4+ T cells.
Xie JH; Nomura N; Koprak SL; Quackenbush EJ; Forrest MJ; Rosen H
J Immunol; 2003 Apr; 170(7):3662-70. PubMed ID: 12646631
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.
Zeng M; Guinet E; Nouri-Shirazi M
Transpl Immunol; 2009 Dec; 22(1-2):82-92. PubMed ID: 19635560
[TBL] [Abstract][Full Text] [Related]
14. A direct method for the calculation of alloreactive CD4+ T cell precursor frequency.
Noorchashm H; Lieu YK; Rostami SY; Song HK; Greeley SA; Bazel S; Barker CF; Naji A
Transplantation; 1999 May; 67(9):1281-4. PubMed ID: 10342323
[TBL] [Abstract][Full Text] [Related]
15. Microchimerism, donor dendritic cells, and alloimmune reactivity in recipients of Flt3 ligand-mobilized hemopoietic cells: modulation by tacrolimus.
Morelli AE; Antonysamy MA; Takayama T; Hackstein H; Chen Z; Qian S; Zurowski NB; Thomson AW
J Immunol; 2000 Jul; 165(1):226-37. PubMed ID: 10861056
[TBL] [Abstract][Full Text] [Related]
16. Murine acute graft-versus-host disease can be prevented by depletion of alloreactive T lymphocytes using activation-induced cell death.
Hartwig UF; Robbers M; Wickenhauser C; Huber C
Blood; 2002 Apr; 99(8):3041-9. PubMed ID: 11929798
[TBL] [Abstract][Full Text] [Related]
17. Dynamics and requirements of T cell clonal expansion in vivo at the single-cell level: effector function is linked to proliferative capacity.
Gudmundsdottir H; Wells AD; Turka LA
J Immunol; 1999 May; 162(9):5212-23. PubMed ID: 10227995
[TBL] [Abstract][Full Text] [Related]
18. Fluorescent target array T helper assay: a multiplex flow cytometry assay to measure antigen-specific CD4+ T cell-mediated B cell help in vivo.
Quah BJ; Wijesundara DK; Ranasinghe C; Parish CR
J Immunol Methods; 2013 Jan; 387(1-2):181-90. PubMed ID: 23123200
[TBL] [Abstract][Full Text] [Related]
19. Donor cell induced CD69 expression and intracellular IL-2 and IL-4 production by peripheral blood lymphocytes isolated from kidney transplant recipients.
Paglieroni TG; Perez R; Katznelson S; Muto K; Chang T; Scott S; MacKenzie MR; Holland PV
Hum Immunol; 1999 Jan; 60(1):41-56. PubMed ID: 9952026
[TBL] [Abstract][Full Text] [Related]
20. Anti-CD3 epsilon F(ab')2 fragments inhibit T cell expansion in vivo during graft-versus-host disease or the primary immune response to nominal antigen.
Blazar BR; Jenkins MK; Taylor PA; White J; Panoskaltsis-Mortari A; Korngold R; Vallera DA
J Immunol; 1997 Dec; 159(12):5821-33. PubMed ID: 9550378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
